Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database

医学 心室辅助装置 心力衰竭 目的地治疗 循环系统 内科学 心脏病学 入射(几何) 变向性 血尿素氮 数据库 外科
作者
Chris J. Kapelios,Lars Lund,Omar Wever-Pinzon,Craig H. Selzman,Susan L Myers,R.S. Cantor,Josef Stehlik,Themistocles Chamogeorgakis,Stephen H. McKellar,Antigone Koliopoulou,Rami Alharethi,Abdallah G Kfoury,Michael Bonios,Stamatis Adamopoulos,Edward M Gilbert,James C. Fang,James K Kirklin,Stavros G. Drakos
出处
期刊:Circulation-heart Failure [Lippincott Williams & Wilkins]
卷期号:15 (6)
标识
DOI:10.1161/circheartfailure.121.008706
摘要

Background: Our current understanding of right heart failure (RHF) post-left ventricular assist device (LVAD) is lacking. Recently, a new Interagency Registry for Mechanically Assisted Circulatory Support definition of RHF was introduced. Based on this definition, we investigated natural history, risk factors, and outcomes of post-LVAD RHF. Methods: Patients implanted with continuous flow LVAD between June 2, 2014, and June 30, 2016 and registered in the Interagency Registry for Mechanically Assisted Circulatory Support/Society of Thoracic Surgeons Database were included. RHF incidence and predictors, and survival after RHF were assessed. The manifestations of RHF which were separately analyzed were elevated central venous pressure, peripheral edema, ascites, and use of inotropes. Results: Among 5537 LVAD recipients (mean 57±13 years, 49% destination therapy, support 18.9 months) prevalence of 1-month RHF was 24%. Of these, RHF persisted at 12 months in 5.3%. In contrast, de novo RHF, first identified at 3 months, occurred in 5.1% and persisted at 12 months in 17% of these, and at 6 months occurred in 4.8% and persisted at 12 months in 25%. Higher preimplant blood urea nitrogen (ORs,1.03–1.09 per 5 mg/dL increase; P <0.0001), previous tricuspid valve repair/replacement (ORs, 2.01–10.09; P <0.001), severely depressed right ventricular systolic function (ORs,1.17–2.20; P =0.004); and centrifugal versus axial LVAD (ORs,1.15–1.78; P =0.001) represented risk factors for RHC incidence at 3 months. Patients with persistent RHF at 3 months had the lowest 2-year survival (57%) while patients with de novo RHF or RHF which resolved by 3 months had more favorable survival outcomes (75% and 78% at 2 years, respectively; P <0.001). Conclusions: RHF at 1 or 3 months post-LVAD was a common and frequently transient condition, which, if resolved, was associated with relatively favorable prognosis. Conversely, de novo, late RHF post-LVAD (>6 months) was more frequently a persistent disorder and associated with increased mortality. The 1-, 3-, and 6-month time points may be used for RHF assessment and risk stratification in LVAD recipients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
初醒完成签到,获得积分10
1秒前
深海鱼完成签到,获得积分10
1秒前
李优秀完成签到,获得积分10
1秒前
天庚地寅完成签到,获得积分10
1秒前
1秒前
3123939715完成签到,获得积分10
2秒前
一区的神完成签到,获得积分10
2秒前
2秒前
霡霂发布了新的文献求助10
2秒前
YanYan完成签到,获得积分10
2秒前
3秒前
3秒前
13发布了新的文献求助10
3秒前
dd完成签到,获得积分20
3秒前
龙科发布了新的文献求助10
4秒前
S1mon完成签到,获得积分10
5秒前
年轻新儿完成签到,获得积分10
6秒前
QAQ完成签到,获得积分10
6秒前
Akim的应助被咎如天采纳,获得10
6秒前
li发布了新的文献求助10
7秒前
7秒前
viviji完成签到,获得积分10
7秒前
中和皇极完成签到,获得积分0
7秒前
7秒前
Eiffel发布了新的文献求助30
7秒前
7秒前
娟娟完成签到,获得积分10
8秒前
风中柚子完成签到 ,获得积分10
8秒前
8秒前
xiao发布了新的文献求助10
9秒前
JamesPei的应助被Akin采纳,获得10
9秒前
Juvenilesy的应助被stangkk采纳,获得10
10秒前
Learn123完成签到,获得积分10
10秒前
CodeCraft的应助被stangkk采纳,获得10
10秒前
雷小仙儿完成签到,获得积分10
10秒前
牧笛完成签到,获得积分10
10秒前
10秒前
所所的应助被丰富冥王星采纳,获得30
10秒前
LNVEFC完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8174058
求助须知:如何正确求助?哪些是违规求助? 9566129
关于积分的说明 21784894
捐赠科研通 7768250
什么是DOI,文献DOI怎么找? 3431686
关于科研通互助平台的介绍 2555907
邀请新用户注册赠送积分活动 2476936